| Literature DB >> 30201912 |
Li Feng1, Xiaojing Wang2, Fei Peng3, Jianqiao Liao4, Yifan Nai5, Hongjie Lei6, Mei Li7, Huaide Xu8.
Abstract
In recent years, with an increase in the aging population, neurodegenerative diseases have attracted more and more attention. This study aimed to investigate the potential neuroprotective effect of defatted walnut meal protein hydrolysates (DWMPH) on neurotoxicity induced by d-galactose (d-gal) and aluminum chloride (AlCl₃) in mice. The animal models were established by combining treatments with d-gal (200 mg/kg/day, subcutaneously) and AlCl₃ (100 mg/kg in drinking water) for 90 days. During the 90 days, 1 g/kg of DWMPH was administrated orally every day. The results indicated that DWMPH treatment alleviated oxidative stress, reversed cholinergic dysfunction, and suppressed the release of proinflammatory cytokines in the brains of d-gal + AlCl₃-treated mice, and thus improving the learning and memory functions of these mice, which was closely correlated with the strong antioxidant activity of DWMPH. This finding suggests that DWMPH might be a promising dietary supplement in improving neuronal dysfunctions of the brain.Entities:
Keywords: aluminum chloride; antioxidant activity; d-galactose; gastrointestinal digestion; neurotoxicity; walnut protein hydrolysates
Mesh:
Substances:
Year: 2018 PMID: 30201912 PMCID: PMC6225279 DOI: 10.3390/molecules23092308
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Initial body weight, final body weight, and food intake of each group. DWMPH—defatted walnut meal protein hydrolysates.
| Group | Initial Body Weight (g) | Final Body Weight (g) | Food Intake (g/day) |
|---|---|---|---|
| Control | 32.40 ± 1.88 | 43.10 ± 3.29 | 7.10 ± 1.24 |
| 30.84 ± 2.36 | 41.93 ± 3.91 | 7.12 ± 0.41 | |
| 31.01 ± 2.74 | 43.70 ± 4.19 | 6.50 ± 0.43 | |
| DWMPH | 32.65 ± 1.97 | 41.72 ± 3.97 | 6.23 ± 0.40 |
Figure 1Timeline illustrates establishment of mice model, defatted walnut meal protein hydrolysates (DWMPH) treatment and assessments of cognitive functions of mice. (A) Experimental schedule for investigating the effect of DWMPH on cognitive impairment induced by d-galactose (d-gal) and aluminum chloride (AlCl3). Effect of DWMPH on total arm entries (B) and spontaneous alternation (C) in Y-maze task were recorded. Escape latency (D), time spent in target quadrant (E), and number of platform crossings (F) in the Morris water maze test were also recorded. The data are expressed as means ± standard deviation (SD). * p < 0.05 vs. control group; # p < 0.05 vs. d-gal + AlCl3 group.
Figure 2Effect of DWMPH on the changes of neuronal morphology induced by d-gal and AlCl3. Brain tissues (cortex and hippocampus) stained with hematoxylin-eosin (HE). The arrows indicate the apoptotic neurons.
Figure 3Alleviation of DWMPH on oxidative damage and cholinergic dysfunction in mice brain. The activities of superoxide dismutase (SOD) (A) and glutathione peroxidase (GSH-Px) (C), as well as the content of malondialdehyde (MDA) (B) in brains, were measured. The acetylcholine esterase (AChE) activity (D), choline acetyltransferase (ChAT) activity (E), and levels of acetylcholine (ACh) (F) related to cholinergic dysfunction in the mouse brain were also determined. The data are expressed as means ± SD. * p < 0.05 vs. control group, # p < 0.05 vs. the d-gal + AlCl3 group.
Figure 4DWMPH reduces the expressions of inflammatory factors tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β). (A) Hippocampus stained by the immunohistochemical approach. Representative photomicrographs of the TNF-α and IL-1β expressions are shown. The levels of TNF-α (B) and IL-1β (C) were also measured by enzyme-linked immunoassay (ELISA). Data are expressed as means ± SD. * p <0.05 vs. control group.
Amino acid composition and essential amino acid evaluation of DWMPH.
| Amino Acid | Content (g/100 g) | Amino Acid | Content (g/100 g) | ||
|---|---|---|---|---|---|
| DWMP | DWMPH | DWMP | DWMPH | ||
| Glu | 24.239 ± 0.242a | 23.495 ± 0.616a | Lys | 2.911 ± 0.139a | 3.536 ± 0.218a |
| Arg | 15.048 ± 0.293a | 13.874 ± 0.320b | Tyr | 2.688 ± 0.203a | 2.456 ± 0.252a |
| Asp | 9.283 ± 0.569a | 11.002 ± 0.430a | Thr | 2.658 ± 0.123a | 2.956 ± 0.209a |
| Leu | 6.763 ± 0.166a | 6.624 ± 0.144a | His | 2.440 ± 0.200a | 2.278 ± 0.114a |
| Val | 5.050 ± 0.227a | 4.869 ± 0.311a | Met | 1.618 ± 0.196a | 1.270 ± 0.163a |
| Gly | 4.830 ± 0.223b | 5.650 ± 0.134a | Trp | 0.848 ± 0.064a | 1.029 ± 0.130a |
| Phe | 4.507 ± 0.178a | 4.300 ± 0.248a | Cys | 0.582 ± 0.074a | 0.473 ± 0.066a |
| Ile | 4.392 ± 0.352a | 4.430 ± 0.235a | Met + Cys | 2.199 ± 0.270a | 1.742 ± 0.229a |
| Ala | 4.152 ± 0.137a | 4.316 ± 0.165a | Phe + Tyr | 7.195 ± 0.025a | 6.753 ± 0.004b |
| Ser | 4.014 ± 0.173a | 4.592 ± 0.163a | |||
| Pro | 3.980 ± 0.243a | 2.857 ± 0.153b | EAA/TAA (%) | 28.745 ± 0.267a | 29.009 ± 0.423a |
The values in a column with different letters indicate significant differences (p < 0.05).
Figure 5The chemical characteristics of DWMPH. The FTIR spectra of DWMPH (B) compared with DWMP (A). (C) The chromatogram of DWMPH by gel chromatography. (D) The molecular weight (MW) distribution of DWMPH. (E) Antioxidant activities of DWMPH evaluated by 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging activity and oxygen radical absorbance capacity (ORAC) compared to that of GSH. Data are expressed as means ± SD. * p < 0.05 vs. DWMPH.
Figure 6The mechanism of DWMPH on alleviation of d-gal and AlCl3 induced neurotoxicity in mice.